In conversation with Forbes Australia Magazine
With lots of milestones happening locally and globally, there was no shortage of topics for conversation when founder and CEO Professor Mark Kendall appeared on 4BC Weekend Breakfast with Olympia Kwitowski.
Media spotlight: Queensland Business Weekend
As we head towards the 2032 Olympics in Brisbane, we have a unique opportunity to draw on their influence to shape a uniquely Australian approach to entrepreneurship.
But what does that represent and how do we get there? They’re powerful questions founder and CEO Professor Mark Kendall had the chance to explore in a guest column he wrote for Queensland Business Weekly in The Courier-Mail.
In conversation with The Courier-Mail
As WearOptimo works towards the release of its hydration Microwearable sensor, The Courier-Mail has shared details of its Advanced Manufacturing Facility (AMF).
Life Sciences Queensland honours Professor Mark Kendall
Proud day for WearOptimo, with recognition for our founder and CEO Professor Mark Kendall at the 2024 GENE Awards run by Life Sciences Queensland.
In conversation with The Australian
WearOptimo CEO and founder Professor Mark Kendall is used to thinking globally. But his biggest dream incorporates a homegrown ambition.
In conversation with WIRED
Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.
The backing of a proven sporting degree
WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.
A critical conversation with Planet Hope
Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.
Trials attract national attention
In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.
Manufacturing project worth $3.9 million
We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.